BACKGROUND: Coagulation factor XI (FXI) inhibitors are a promising and novel class of anticoagulants, but a recent animal study found that FXI inhibition exacerbated diastolic dysfunction and heart ...

Initial Coagulation Studies ... each of the 13 patients was associated with decreased factor V activity. Factors VII and X (combined assay) and II were each decreased in 12 of the 13 patients.

Two assays, one for lupus anticoagulant antibodies ... Impact of the Antiphospholipid Syndrome: A Critical Coagulation Disorder in Women. MedGenMed 1(2), 1999. [formerly published in Medscape ...